FDA evaluating 3 applications for kids, teens' jabs | Inquirer News
Close  

FDA evaluating 3 applications for kids, teens’ jabs

/ 03:04 AM January 18, 2022

MANILA, Philippines — The Food and Drug Administration (FDA) is evaluating applications of three vaccine makers for an amendment to their emergency use authorization (EUA) to allow the use of their jabs for children and teens.

ADVERTISEMENT

Bharat Biotech’s Covaxin, Sinovac’s CoronaVac, and the vaccine developed by China state-owned Sinopharm currently have pending EUA amendment applications before the FDA, acting Director-General Oscar Gutierrez told President Rodrigo Duterte in the weekly taped “Talk to the People” that aired late Monday night.

“If these three will pass our clinical evaluation and the standards of the FDA, we will have five vaccines for the immediate future,” he said in Filipino.

FEATURED STORIES

Bharat Biotech is applying for an EUA amendment for the use of Covaxin on those aged 2 to 18.

Sinovac’s application is for the use of its vaccine on those aged 3 to 11 and 12 to 17.

Sinopharm has an application for the use of its vaccine on those aged 3 to 17.

The FDA has only so far approved the use of Moderna and Pfizer vaccines on those aged 12 and above. Pfizer’s vaccine for use on those aged 5 to 11 has also been approved.

At present, the youngest who can receive COVID-19 jabs in the country are those aged 12.

The government is eyeing to start the vaccination of those aged 5 to 11 by February.

RELATED STORIES

ADVERTISEMENT

Pfizer jabs OK’d for kids age 5-11

Kids aged 5 to 11 to be vaccinated in February

ATM

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.
Read Next
Don't miss out on the latest news and information.

Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer & other 70+ titles, share up to 5 gadgets, listen to the news, download as early as 4am & share articles on social media. Call 896 6000.

TAGS: bharat biotech, COVID-19 vaccination for children, FDA, Oscar Gutierrez, Sinopharm, Sinovac
For feedback, complaints, or inquiries, contact us.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and
acknowledge that I have read the Privacy Policy.



© Copyright 1997-2022 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.